This document provides an overview of the pancreas and diabetes mellitus. It discusses the pancreas' roles in hyper-secretion and hypo-secretion. It then covers the classification, causes, signs and symptoms, complications and treatment of diabetes mellitus. The two main types of diabetes discussed are type I diabetes, which results from insulin deficiency, and type II diabetes, which results from insulin resistance. Diabetic ketoacidosis and hypoglycemic coma are also summarized.
Posterior Pituitary or Neurohypophysis composed mainly of glial-like cells called pituicytes.
The pituicytes do not secrete hormones.
They act simply as a supporting structure for large numbers
of terminal nerve fibers and terminal nerve endings from nerve tracts.
That originate in the supraoptic and paraventricular
nuclei of the hypothalamus.
anatomy of duodenum, location or position of duodenum, parts of duodenum, relations of each parts of duodenum, ligaments of treitz, visceral and peritoneal relation of duodenum, blood supply of duodenum, innervation of duodenum, clinical aspects of duodenum, duodenal ulcer, diverticulum, deodinitis, duodenal obstruction
Physiology of thyroid gland and pancreas
fail safe mechanism of pancreas
physiology in short with more pictures
Easy to understand the Physiology of these vital glands
Posterior Pituitary or Neurohypophysis composed mainly of glial-like cells called pituicytes.
The pituicytes do not secrete hormones.
They act simply as a supporting structure for large numbers
of terminal nerve fibers and terminal nerve endings from nerve tracts.
That originate in the supraoptic and paraventricular
nuclei of the hypothalamus.
anatomy of duodenum, location or position of duodenum, parts of duodenum, relations of each parts of duodenum, ligaments of treitz, visceral and peritoneal relation of duodenum, blood supply of duodenum, innervation of duodenum, clinical aspects of duodenum, duodenal ulcer, diverticulum, deodinitis, duodenal obstruction
Physiology of thyroid gland and pancreas
fail safe mechanism of pancreas
physiology in short with more pictures
Easy to understand the Physiology of these vital glands
From famous actors like Patrick Swayze to America's first woman in space, Sally Ride, the survival rates for pancreatic cancer summarizes grim tales. To date, the overall 5-year-survival rate is 6.7%. Here, I present some of the latest information in the field.
The PPT on Diabetes Mellites. Check out the presentation right away!
To download original, editable and non-watermark PowerPoint Presentation check,
https://resorcio.com/products/diabetes-mellites
To watch more similar PPTs visit www.resorcio.com
Join live classes, download study aids, sell your documents, join or host your own classes online, get tutoring, tutor students, take practices tests and more at Examville.com
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
3. Diabetes Mellitus
Diabetes mellitus is a metabolic disorder
characterized by high blood glucose level,
associated with other manifestations.
In most of the cases, diabetes mellitus develops
due to deficiency of insulin.
4. Classification Of Diabetes Mellitus
Several forms of diabetes mellitus, which occur due
to different causes.
Diabetes may be:
1. Primary:
Diabetes that is unrelated to another disease.
2. Secondary:
Diabetes that occurs due to damage or disease of
pancreas by another disease or factor.
5. Recent classification divides primary diabetes
mellitus into two types:
1. Type I DM
2. Type II DM
6. Type I Diabetes Mellitus
It is due to deficiency of insulin because of
destruction of β-cells in islets of Langerhans.
This type of diabetes mellitus may occur at any age
of life.
But, it usually occurs before 40 years of age and the
persons affected by this require insulin injection.
Also called insulin-dependent diabetes mellitus
(IDDM).
7. When it develops at infancy or childhood, it is
called juvenile diabetes
It develops rapidly and progresses at a rapid phase.
It is not associated with obesity, but may be
associated with acidosis or ketosis.
8. Causes of Type I diabetes mellitus
Degeneration of β-cells in the islets of Langerhans of
pancreas by viral or auto-immune disease.
Congenital disorder of β-cells
9. Other forms of type 1 diabetes mellitus
1. Latent autoimmune diabetes in adults (LADA):
LADA or slow onset diabetes has slow onset and
slow progress than IDDM and it occurs in later life
after 35 years.
It may be difficult to distinguish LADA from type II
diabetes mellitus, since pancreas takes longer
period to stop secreting insulin.
10. 2. Maturity onset diabetes in young individuals
(MODY):
It is a rare inherited form of diabetes mellitus that
occurs before 25 years.
It is due to hereditary defects in insulin secretion.
11. Type II Diabetes Mellitus
It is due to insulin resistance (failure of insulin
receptors to give response to insulin).
So, the body is unable to use insulin.
About 90% of diabetic patients have type II
diabetes mellitus.
It usually occurs after 40 years.
12. Only some forms of Type II diabetes require insulin.
In most cases, it can be controlled by oral
hypoglycemic drugs.
Also called Non-insulin dependent diabetes mellitus
(NIDDM).
Type II diabetes mellitus may or may not be
associated with ketosis, but often it is associated
with obesity.
13. Causes for type II Diabetes Mellitus
Structure and function of β-cells and blood level of
insulin are normal.
But insulin receptors may be less, absent or abnormal,
resulting in insulin resistance.
Common causes of insulin resistance are:
1. Genetic disorders (significant factors causing type II
diabetes mellitus)
2. Lifestyle changes such as bad eating habits and physical
inactivity, leading to obesity
3. Stress
14. Insulin resistance is part of cascade of syndrome called
the “metabolic syndrome."
Some of the features of the metabolic syndrome
include:
1. Obesity, especially accumulation of abdominal fat;
2. Insulin resistance;
3. Fasting hyperglycemia;
4. Lipid abnormalities, such as increased blood triglycerides
and decreased blood high-density lipoprotein-cholesterol;
5. Hypertension
15. Other forms of type II diabetes mellitus
1. Gestational diabetes:
It occurs during pregnancy.
It is due to many factors such as hormones secreted
during pregnancy, obesity and lifestyle before and
during pregnancy.
Usually, diabetes disappears after delivery of the child.
However, the woman has high risk of development of
type II diabetes later.
16.
17. Secondary Diabetes Mellitus
Secondary diabetes mellitus is rare and only about
2% of diabetic patients have secondary diabetes.
It may be temporary or may become permanent
due to the underlying cause.
18. Causes of secondary diabetes mellitus
1. Endocrine disorders such as gigantism, acromegaly
and Cushing’s syndrome, polycystic ovarian
syndrome
2. Damage of pancreas due to disorders such as
chronic pancreatitis, cystic fibrosis and
hemochromatosis (high iron content in body causing
damage of organs)
3. Pancreatectomy (surgical removal)
4. Liver diseases such as hepatitis C and fatty liver
19. 5. Autoimmune diseases such as celiac disease
6. Excessive use of drugs like antihypertensive drugs
(beta blockers and diuretics), steroids, oral
contraceptives, chemotherapy drugs, etc.
7. Excessive intake of alcohol and opiates.
20. Signs and Symptoms of Diabetes Mellitus
Various manifestations of diabetes mellitus develop
because of three major setbacks of insulin deficiency.
1. Increased blood glucose level (300 to 400 mg/dL)
due to reduced utilization by tissue
2. Mobilization of fats from adipose tissue for energy
purpose, leading to elevated fatty acid content in
blood. This causes deposition of fat on the wall of
arteries and development of atherosclerosis
3. Depletion of proteins from the tissues.
21. Following are the signs and symptoms of diabetes
1. Glucosuria
2. Osmotic diuresis
3. Polyuria
4. Polydipsia
5. Polyphagia
6. Asthenia
23. Glucosuria
It is the loss of glucose in urine.
Normally, glucose does not appear in urine.
When glucose level rises above 180 mg/dL (renal
threshold level for glucose in blood) glucose
appears in urine
24. Osmotic diuresis
The diuresis caused by osmotic effects.
Excess glucose in the renal tubules develops
osmotic effect.
Osmotic effect decreases the reabsorption of water
from renal tubules, resulting in diuresis.
It leads to polyuria and polydipsia
25. Polyuria
Excess urine formation with increase in the
frequency of voiding urine is called polyuria.
It is due to the osmotic diuresis caused by increase
in blood glucose level.
26. Polydipsia
Increase in water intake is called polydipsia.
Excess loss of water decreases the water content
and increases the salt content in the body.
This stimulates the thirst center in hypothalamus.
Thirst center, in turn increases the intake of water.
27. Polyphagia
Polyphagia means the intake of excess food.
It is very common in diabetes mellitus.
28. Asthenia
Loss of strength is called asthenia.
Body becomes very weak because of this.
Asthenia occurs due to protein depletion, which is
caused by lack of insulin.
Lack of insulin causes decrease in protein synthesis
and increase in protein breakdown, resulting in
protein depletion.
29. Protein depletion also occurs due to the utilization
of proteins for energy in the absence of glucose
utilization.
30. Acidosis
During insulin deficiency, glucose cannot be utilized by
the peripheral tissues for energy.
So, a large amount of fat is broken down to release
energy.
It causes the formation of excess ketoacids, leading to
acidosis.
One more reason for acidosis is that the ketoacids are
excreted in combination with sodium ions through
urine (ketonuria).
31. Sodium is exchanged for hydrogen ions, which diffuse
from the renal tubules into ECF adding to acidosis.
32. Acetone Breathing
In cases of severe ketoacidosis, acetone is expired
in the expiratory air, giving the characteristic
acetone or fruity breath odor.
It is a life-threatening condition of severe diabetes.
33. Kussmaul breathing
Kussmaul breathing is the increase in rate and
depth of respiration caused by severe acidosis.
34. Circulatory Shock
Osmotic diuresis leads to dehydration, which causes
circulatory shock.
It occurs only in severe diabetes.
35. Coma
Due to Kussmaul breathing, large amount of carbon
dioxide is lost during expiration.
It leads to drastic reduction in the concentration of
bicarbonate ions causing severe acidosis and coma.
It occurs in severe cases of diabetes mellitus.
Increase in the blood glucose level develops hyper-
osmolarity of plasma which also leads to coma.
It is called hyperosmolar coma.
36. Diabetic ketoacidosis
It is an acute pathologic event characterized by
elevated blood glucose levels and ketone bodies
and metabolic acidosis
It results directly from decreased insulin availability
and simultaneous elevations of the counter
regulatory hormones glucagon, catecholamines,
cortisol, and growth hormone.
37. In diabetic ketoacidosis, gluconeogenesis in the liver
proceeds unopposed by the physiologic presence of
insulin.
The excess blood glucose increases osmolarity, which,
if severe, can result in diabetic coma.
Low insulin levels and the high levels of
counterregulatory hormones glucagon, epinephrine,
and cortisol combine to increase the activity of
hormone-sensitive lipase, increase the release of free
fatty acids, and decrease the activity of acetyl-CoA
carboxylase, thereby impairing the reesterification of
free fatty acids and promoting fatty acid conversion
into ketone bodies.
38. The steps involved in ketogenesis are β-oxidation of
fatty acids to acetyl-CoA, formation of acetoacetyl-
CoA, and conversion of acetoacetyl-CoA to 3-
hydroxy-3-methylglutaryl- CoA and then to
acetoacetate, which is then reduced to 3-
hydroxybutyrate.
Acetoacetate can be spontaneously
decarboxylated to acetone, a highly fat-soluble
compound that is excreted slowly by the lungs and
is responsible for the fruity odor of the breath of
individuals with diabetic ketoacidosis.
39. Ketone bodies released into the blood can freely
diffuse across cell membranes and serve as an
energy source for extrahepatic tissues including the
brain, skeletal muscle, and kidneys.
Ketone bodies are filtered and reabsorbed in the
kidney.
At physiologic pH, ketone bodies, with the
exception of acetone, dissociate completely.
40. The resulting liberation of H+ from ketone body
metabolism exceeds the blood’s buffering
capacity, leading to metabolic acidosis with an
increased anion gap.
If severe, this condition can lead to coma
44. Diabetic Comas
Diabetic Coma
1. Hypoglycemic coma
It is a result of treatment and not a manifestation of the
disease itself.
It is usually mild enough to be reversed by eating of
drinking carbohydrates.
45. 2. Dibetic ketoacidosis coma
3. Non ketotic hyperosmolar coma
Blood glucose level above 900mg/dL, causing severe
osmotic diuresis resulting in dehayration.
Normal blood osmolarity is between 280-300mmol/kg
and when it rises above 340 mmol/kg the conscious
level is disturbed.
46.
47. Complications of Diabetes Mellitus
Prolonged hyperglycemia in diabetes mellitus
causes dysfunction and injury of many tissues,
resulting in some complications.
Development of these complications is directly
proportional to the degree and duration of
hyperglycemia.
However, the patients with well controlled diabetes
can postpone the onset or reduce the rate of
progression of these complications.
48. Vascular complications are responsible for the
development of most of the complications of
diabetes such as:
Cardiovascular complications like:
Hypertension
Myocardial infarction
Degenerative changes in retina called diabetic
retinopathy
49. Degenerative changes in kidney known as diabetic
nephropathy
Degeneration of autonomic and peripheral nerves
called diabetic neuropathy.
50. Diagnostic Tests for Diabetes Mellitus
Diagnosis of diabetes mellitus includes the
determination of:
1. Fasting blood glucose
2. Postprandial blood glucose
3. Glucose tolerance test (GTT)
4. Glycosylated (glycated) hemoglobin.
5. Urine glucose level testing
53. Treatment for Diabetes Mellitus
Type I diabetes mellitus
Treated by exogenous insulin.
Since insulin is a polypeptide, it is degraded in GI
tract if taken orally.
So, it is generally administered by subcutaneous
injection.
54. Type II diabetes mellitus
Type II diabetes mellitus is treated by oral
hypoglycemic drugs.
Patients with longstanding severe diabetes mellitus
may require a combination of oral hypoglycemic
drugs with insulin to control the hyperglycemia.
55. Oral hypoglycemic drugs are classified into three
types:
1. Insulin Secretagogues
These drugs decrease the blood glucose level by
stimulating insulin secretion from β-cells.
Sulfonylureas (tolbutamide, gluburide, glipizide) are
the commonly available insulin secretagogues
56. 2. Insulin Sensitizers
These drugs decrease the blood glucose level by
facilitating the insulin action in the target tissues.
Examples are biguanides (metformin) and
thiazolidinediones (pioglitazone and rosiglitazone)
57. 3. Alpha Glucosidase Inhibitors
These drugs control blood glucose level by inhibiting
α-glucosidase.
This intestinal enzyme is responsible for the
conversion of dietary and other complex
carbohydrates into glucose and other
monosaccharides, which can be absorbed from
intestine.
Examples of α-glucosidase inhibitors are acarbose
and meglitol
59. Cause of Hyperinsulinism
Hyperinsulinism occurs due to the tumor of β-cells in
the islets of Langerhans.
60. Signs and Symptoms of Hyperinsulinism
1. Hypoglycemia
Blood glucose level falls below 50 mg/dL.
61. 2. Manifestations of central nervous system
CNS manifestation occurs when blood glucose level
decreases.
All the manifestations are together called
neuroglycopenic symptoms.
Initially, the activity of neurons increases, resulting in
nervousness, tremor all over the body and sweating.
If not treated immediately, it leads to clonic
convulsions and unconsciousness.
62. Slowly, the convulsions cease and coma occurs
due to the damage of neurons